Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -23.46%35.06M | -19.86%68.62M | -15.94%45.8M | 16.67%85.62M | 20.88%54.49M | 5.27%25.64M | -7.00%73.38M | 2.23%65.66M | 1.64%45.07M | 14.23%24.36M |
| Operating income | -23.46%35.06M | -19.86%68.62M | -15.94%45.8M | 16.67%85.62M | 20.88%54.49M | 5.27%25.64M | -7.00%73.38M | 2.23%65.66M | 1.64%45.07M | 14.23%24.36M |
| Cost of sales | 29.47%-13.6M | 18.75%-30.13M | 10.25%-19.28M | 5.82%-37.08M | -10.12%-21.49M | 2.64%-10.37M | -4.09%-39.38M | -13.19%-32.79M | -8.84%-19.51M | -15.84%-10.65M |
| Operating expenses | 29.47%-13.6M | 18.75%-30.13M | 10.25%-19.28M | 5.82%-37.08M | -10.12%-21.49M | 2.64%-10.37M | -4.09%-39.38M | -13.19%-32.79M | -8.84%-19.51M | -15.84%-10.65M |
| Gross profit | -19.09%21.45M | -20.70%38.49M | -19.65%26.52M | 42.71%48.53M | 29.10%33M | 11.42%15.28M | -17.21%34.01M | -6.77%32.87M | -3.24%25.56M | 13.02%13.71M |
| Administrative expenses | 9.57%-13.1M | -1.20%-31.08M | -8.96%-14.49M | -12.89%-30.71M | -4.76%-13.3M | 2.81%-6.01M | 2.87%-27.21M | -5.09%-18.78M | -5.71%-12.69M | -6.03%-6.19M |
| Impairment and provision | ---- | 233.29%2.28M | ---- | -288.21%-1.71M | ---- | ---- | -39.56%-441K | -91.75%24K | -91.72%24K | ---- |
| -Other impairment is provision | ---- | 233.29%2.28M | ---- | -288.21%-1.71M | ---- | ---- | -39.56%-441K | -91.75%24K | -91.72%24K | ---- |
| Special items of operating profit | -52.15%545K | -37.32%1.24M | -21.34%1.14M | 77.13%1.98M | 109.55%1.45M | 233.20%321K | 21.20%1.12M | 52.09%1.05M | -6.37%691K | -1,821.43%-241K |
| Operating profit | -32.43%8.9M | -39.60%10.92M | -37.76%13.17M | 141.93%18.08M | 55.71%21.15M | 31.59%9.59M | -45.32%7.47M | -17.43%15.17M | -12.01%13.58M | 11.36%7.28M |
| Financing cost | 23.08%-80K | -49.25%-200K | -22.35%-104K | 40.71%-134K | 12.37%-85K | -11.90%-47K | -73.85%-226K | -54.55%-170K | -19.75%-97K | 4.55%-42K |
| Earning before tax | -32.50%8.82M | -40.26%10.72M | -38.00%13.06M | 147.63%17.95M | 56.19%21.07M | 31.70%9.54M | -46.47%7.25M | -17.87%15M | -12.18%13.49M | 11.47%7.24M |
| Tax | 35.42%-1.38M | 48.30%-1.29M | 44.11%-2.14M | -122.19%-2.49M | -86.57%-3.83M | 42.41%-713K | 48.25%-1.12M | 15.74%-2.61M | 0.48%-2.06M | -19.85%-1.24M |
| After-tax profit from continuing operations | -31.93%7.43M | -38.96%9.43M | -36.64%10.92M | 152.29%15.46M | 50.73%17.23M | 46.99%8.83M | -46.13%6.13M | -18.30%12.39M | -13.99%11.43M | 9.88%6M |
| Earning after tax | -31.93%7.43M | -38.96%9.43M | -36.64%10.92M | 152.29%15.46M | 50.73%17.23M | 46.99%8.83M | -46.13%6.13M | -18.30%12.39M | -13.99%11.43M | 9.88%6M |
| Profit attributable to shareholders | -31.93%7.43M | -38.96%9.43M | -36.64%10.92M | 152.29%15.46M | 50.73%17.23M | 46.99%8.83M | -46.13%6.13M | -18.30%12.39M | -13.99%11.43M | 9.88%6M |
| Basic earnings per share | -32.11%0.0074 | -39.35%0.0094 | -36.63%0.0109 | 154.10%0.0155 | 50.88%0.0172 | 46.67%0.0088 | -46.49%0.0061 | -18.42%0.0124 | -14.29%0.0114 | 9.09%0.006 |
| Diluted earnings per share | -32.11%0.0074 | -39.35%0.0094 | -36.63%0.0109 | 154.10%0.0155 | 50.88%0.0172 | 46.67%0.0088 | -46.49%0.0061 | -18.42%0.0124 | -14.29%0.0114 | 9.09%0.006 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | -- | Furimazer Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.